These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12758206)

  • 21. Shifting the focus of tuberculosis research in India.
    Narayanan PR; Garg R; Santha T; Kumaran PP
    Tuberculosis (Edinb); 2003; 83(1-3):135-42. PubMed ID: 12758203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Ministry of Health fully prepared to implement an effective DOTS program in Pakistan? An operations research on TB control program in the public health sector in Sindh.
    Israr SM
    J Pak Med Assoc; 2003 Aug; 53(8):324-7. PubMed ID: 14558734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A research agenda to promote the management of childhood tuberculosis within national tuberculosis programmes.
    Donald PR; Maher D; Qazi S
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):370-80. PubMed ID: 17394681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public-private mix for tuberculosis care and prevention. What progress? What prospects?
    Uplekar M
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1424-1429. PubMed ID: 27776581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engagement of public and private medical facilities in tuberculosis care in Myanmar: contributions and trends over an eight-year period.
    Nwe TT; Saw S; Le Win L; Mon MM; van Griensven J; Zhou S; Chinnakali P; Shah S; Thein S; Aung ST
    Infect Dis Poverty; 2017 Sep; 6(1):123. PubMed ID: 28859677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compliance with DOTS diagnosis and treatment recommendations by private practitioners in Kerala, India.
    Greaves F; Ouyang H; Pefole M; MacCarthy S; Cash RA
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):110-2. PubMed ID: 17217139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of advocacy on the tuberculosis management practices of private practitioners in Chennai City, India.
    Krishnan N; Ananthakrishnan R; Augustine S; Vijayalakshmi NK; Gopi PG; Kumaraswami V; Narayanan PR
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):112-8. PubMed ID: 19105888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Global TB Drug Facility: innovative global procurement.
    Kumaresan J; Smith I; Arnold V; Evans P
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):130-8. PubMed ID: 14974756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Patient-centered medicine for tuberculosis medical services].
    Fujita A; Narita T
    Kekkaku; 2012 Dec; 87(12):795-808. PubMed ID: 23350521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low access to a highly effective therapy: a challenge for international tuberculosis control.
    Dye C; Watt CJ; Bleed D
    Bull World Health Organ; 2002; 80(6):437-44. PubMed ID: 12131999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.
    Yu S; Sohn H; Kim HY; Kim H; Oh KH; Kim HJ; Chung H; Choi H
    PLoS Med; 2021 Jul; 18(7):e1003717. PubMed ID: 34260579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of private and public health-care providers for tuberculosis symptoms in Ho Chi Minh City, Vietnam.
    Lönnroth K; Thuong LM; Linh PD; Diwan VK
    Health Policy Plan; 2001 Mar; 16(1):47-54. PubMed ID: 11238430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the complex relationships among actors involved in the implementation of public-private mix (PPM) for TB control in India, using social theory.
    Salve S; Harris K; Sheikh K; Porter JDH
    Int J Equity Health; 2018 Jun; 17(1):73. PubMed ID: 29880052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is operational research and how can national tuberculosis programmes in low- and middle-income countries use it to end TB?
    Kumar AM; Harries AD; Satyanarayana S; Thekkur P; Shewade HD; Zachariah R
    Indian J Tuberc; 2020 Dec; 67(4S):S23-S32. PubMed ID: 33308668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility and effectiveness of a public-private mix project for improved TB control in Delhi, India.
    Arora VK; Sarin R; Lönnroth K
    Int J Tuberc Lung Dis; 2003 Dec; 7(12):1131-8. PubMed ID: 14677887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public-private mix for DOTS: demanding, but delay will only hamper TB control.
    Uplekar MW
    Int J Tuberc Lung Dis; 2003 Dec; 7(12):1113-4. PubMed ID: 14677884
    [No Abstract]   [Full Text] [Related]  

  • 37. Joining the DOTS in Bali: private practitioners' perceptions of tuberculosis control.
    Watkins RE; Feeney KT; Bakar OA; Plant AJ
    Int J Tuberc Lung Dis; 2006 Sep; 10(9):988-94. PubMed ID: 16964789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Public-private mix TB activities in Meerut, Uttar Pradesh, North India: delivering dots via collaboration with private providers and non-governmental organizations.
    Sehgal S; Dewan PK; Chauhan LS; Sahu S; Wares F; Granich R
    Indian J Tuberc; 2007 Apr; 54(2):79-83. PubMed ID: 17575679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review.
    Hudson M; Rutherford GW; Weiser S; Fair E
    PLoS One; 2018; 13(4):e0194960. PubMed ID: 29634772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustaining PPM-DOTS: the case of Pimpri Chinchwad, Maharashtra, India.
    Pradhan A; Datye V; Kielmann K; Khilare K; Datye A; Inamdar V; Porter J; Rangan S
    Indian J Tuberc; 2011 Jan; 58(1):18-28. PubMed ID: 21434552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.